Perhaps:
https://www.fda.gov/ForPatients/Other/ExpandedAccess/ucm20041768.htm
"Expanded access, also called “compassionate use,” provides a pathway for patients to gain access to investigational drugs, biologics and medical devices for serious diseases or conditions"
Fragile X passes the test for "serious disease" and potentially Rett Syndrome does too. The quality of life is terrible for the patients of both and they also experience reduced life expectancy.
- Forums
- ASX - By Stock
- NEU
- pharmaceutical deals
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.40%
!
$17.09
pharmaceutical deals, page-100
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
